Roth Capital downgraded Bluebird Bio (Nasdaq: BLUE) from a Buy rating to a Neutral rating and slashed its price target fro $121 to $62. The stock price plummeted $31.06 to $52.60.
Bluebird Bio downgraded
December 07, 2015 at 13:12 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.